Data provided by Nasdaq. Minimum 15 minutes delayed.
September 07, 2018
NantHealth Announces Appointment of Two Senior Executives to Lead Strategy, Business Development, and Global Sales
Nikko Khazana and Mark Mozley will help drive growth of NantHealth’s portfolio, including GPS Cancer® and Liquid GPS products CULVER CITY, Calif.--(BUSINESS WIRE)--Sep. 7, 2018-- NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company’s strategy and business development as well as global sales. Nikko Khazana will serve as...
August 09, 2018
NantHealth Reports 2018 Second-Quarter Financial Results
Liquid GPS® Successfully Launched in Q2 Total Revenue in Q2 was $22.0 Million Revenue in 2017 Q2 included a large completed Connected Care device implementation of approximately $4 million, benefiting prior period revenue of $23.5 million SaaS revenue of $16.2 million in Q2, up 9% from $14.9 million in prior year Q2 In June...
August 03, 2018
NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Aug. 3, 2018-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will ...
|There are currently no events scheduled.|